Abstract
The present study was designed to investigate the protective effect of lacteol® forte against thioacetamide (TAA)-induced hepatic damage in rats. Twenty male albino rats were randomly allocated into four groups (five rats each) as followed control group: received 0.2 ml of distilled water/ 100 g B.W./ day orally 5 times/week, TAA-treated group: received an intraperitoneal injection (I/P) of TAA at a dose of 200 mg/kg B.W. twice/ week, Lacteal fort-treated group: received lacteal fort (1 × 109 CFU/rat) orally 5 times/week, and TAA + Lacteal fort: I/P injected with TAA (200 mg/kg B.W.) and lacteal fort was given orally (1 × 109 CFU/rat). Six weeks post-treatment, biochemical results indicated that TAA induced a significant elevation in the serum level of aspartate aminotransferase AST and no significant difference was observed in serum levels of alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) as compared to control. While, no significant changes in serum levels of hepatic enzymes (ALT, AST, and GGT) were recorded. Histopathologically, TAA induced various degenerative, necrotic, fibroblastic and hyperplastic alterations. Conversely, the administration of lacteol® forte improved TAA-induced hepatic histopathologic alterations. In conclusion, lacteol® forte improved serum liver enzymes and liver damage, suggesting it to have useful protective potential against liver injury.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
